• Thu. Oct 22nd, 2020

Dimancherouge

Technology

immune

  • Home
  • Immune T cells swarm to tumours by following a chemical gradient left by other cancer-killing T cells — ScienceDaily

Immune T cells swarm to tumours by following a chemical gradient left by other cancer-killing T cells — ScienceDaily

When immune system T cells find and recognise a target, they release chemicals to attract more T cells which then swarm to help subdue the threat, shows a new study…

Potential new antibiotics work by disrupting bacterial membrane and summoning immune cells in animal models — ScienceDaily

A team led by scientists in the Perelman School of Medicine at the University of Pennsylvania has engineered powerful new antimicrobial molecules from toxic proteins found in wasp venom. The…

Mouse immune study gives pointers for development of vaccines and immune therapies — ScienceDaily

Researchers have charted the activity of tens of thousands of genes in mouse immune cells over the course of an infection. The study from the University of Melbourne, Australia, the…

Immune evasion strategy used by Malaria-causing parasite — ScienceDaily

The Plasmodium parasite, which transmits malaria to humans through infected mosquitos, triggers changes in human genes that alter the body’s adaptive immune response to malarial infections, according to a team…

The making of memory B cells and long-term immune responses

IMAGE: B cell differentiation in GC view more  Credit: Osaka University Osaka, Japan — The current COVID-19 climate has made vaccines, antibodies, and immune responses topics of everyday conversation. Now, it…

Trump claims he is ‘immune’ to coronavirus, but the science is unclear

President Donald Trump claimed that he is “immune” to the coronavirus in a Fox News interview with Maria Bartiromo on Sunday. Though experts think that most people develop an immune…

Preliminary results of two large immune therapy studies show promise in advanced cervical cancer — ScienceDaily

Preliminary results from two independent, phase II clinical trials investigating a new PD-1 (programmed cell death protein 1)-based immune therapy for metastatic cervical cancer suggest potential new treatment options for…

Cells sacrifice themselves to boost immune response to viruses — ScienceDaily

Whether flu or coronavirus, it can take several days for the body to ramp up an effective response to a viral infection. New research appearing in the journal Nature Immunology…

UC Riverside-led study is the first to show how tofacitinib rescues gut barrier function from overactive immune cells — ScienceDaily

A team of researchers led by biomedical scientist Declan F. McCole at the University of California, Riverside, has found that the drug tofacitinib, also called Xeljanz and approved by the…

Children’s immune response more effective against COVID-19 — ScienceDaily

Children and adults exhibit distinct immune system responses to infection by the virus that causes COVID-19, a finding that helps explain why COVID-19 outcomes tend to be much worse in…